AACR INTERNATIONAL: FOSTERING CANCER RESEARCH WORLDWIDE
In September 1989, the AACR organized its first meeting outside North America—a conference on The Cell Membrane and Cell Signals as Targets in Cancer Chemotherapy held at Queens’ College, Cambridge University, United Kingdom. Jointly sponsored with the European Organisation for Research and Treatment of Cancer (EORTC) and the British Association for Cancer Research (BACR), the goal of the conference was to accelerate the development of new cancer treatments by bringing together scientists, chemists, pharmacologists, experimental chemotherapists, and clinicians to identify and exploit new targets.
Since that first international meeting, the AACR has continued and expanded its global outreach, driving innovative cancer science through collaborations with scientific organizations around the world. In 2017, that outreach included the launch of AACR conferences on two new continents.
SOUTH AFRICA: NEW FRONTIERS IN CANCER RESEARCH CONFERENCE
In January, more than 150 participants joined cochairs Peter A. Jones, PhD, DSc, FAACR, and Frank McCormick, PhD, FRS, DSc (hon), FAACR (right), in Cape Town for the first AACR conference held in Africa. The attendees learned about the latest basic, translational, and clinical cancer research, with a special focus on cancers with a high rate of incidence in the region. Recognizing that infrastructure is as critical as innovation in attacking the cancer problem, the AACR worked with the African Organisation for Research and Training in Cancer (AORTIC) to organize a pre-conference workshop on “Capacity Building for Cancer Research,” which addressed the challenges facing basic and clinical researchers in Africa.
BRAZIL: AACR INTERNATIONAL CONFERENCE ON TRANSLATIONAL CANCER MEDICINE
Nearly 400 participants gathered in São Paulo in May for the first AACR conference held in Latin America, which was organized in cooperation with the Latin American Cooperative Oncology Group (LACOG). Conference cochairs Carlos L. Arteaga, MD, FAACR (far right), and Carlos Gil M. Ferreira, MD, PhD (near right), developed a program that bridged the gap between basic and clinical research, particularly for the cancers that are most prevalent in Latin America.
China: New Horizons in Cancer Research Conference
2016-2017 AACR President Nancy Davidson, MD, FAACR, and 2017 Annual Meeting Program Chair Kornelia Polyak, MD, PhD, worked with conference cochairs Chi Van Dang, MD, PhD (right), and Hongyang Wang, MD, PhD, to bring the best of the AACR Annual Meeting to Shanghai for the fourth edition of this landmark conference. More than 500 participants attended the conference in November, which brought international speakers and local experts together to share the latest cutting-edge research.
The AACR worked with seven international scientific organizations in 2017 to develop the following joint conferences and workshops:
Other International Collaborations
The AACR worked with four additional organizations to sponsor sessions at or provide program support for the following conferences:
Inaugural AACR China Industry Roundtable
Extending its mission to support collaboration, in May the AACR hosted a meeting of more than twenty Chinese pharma, biotech, diagnostics, and contract research companies in Shanghai. These industry leaders discussed the challenges and opportunities in cancer research in China and identified areas of focus for which the AACR could develop impactful programs and initiatives in the region.
First AACR Conference on Each Continent
1907 (First AACR meeting; New York, New York)
1989 (AACR-BACR-EORTC Joint Conference on The Cell Membrane and Cell Signals as Targets in Cancer Chemotherapy; Cambridge, England)
1994 (AACR-Academia Sinica Joint Conference on Modern Developments in Cancer Therapeutics; Taipei, Taiwan)
1997 (AACR-Lorne Cancer Conference Joint Conference on Growth Factors, Signaling, and Cancer; Lorne, Victoria, Australia)
2017 (AACR International Conference on New Frontiers in Cancer Research; Cape Town, South Africa)
2017 (AACR International Conference on Translational Cancer Medicine; São Paulo, Brazil)